Research for recessive type of CMT has begun at the Cyprus Institute of Neurology and Genetics
The CMTA is pleased to announce a new STAR research project on CMT4C. Completely funded by the CMTA, the 18-month project headed by Dr. Kleopas A. Kleopa of the Cyprus Institute of Neurology and Genetics will explore the possibility of using gene editing to treat CMT4C.
This is the first time that the CMTA has funded research on a recessive type of CMT, exciting news for everyone with any type of the disease! Through STAR (Strategy to Accelerate Research), we are now attacking CMT1A, CMT1B, CMT1X, CMT2A, CMT2E and CMT4C.* We truly believe that research for any type of CMT helps all types of CMT.
If you would like to support the CMT4C project or any of STAR’s work, please click here to donate.
We will keep you posted on Dr. Kleopa’s progress. Thanks for supporting STAR!
*To learn more about STAR, please visit www.cmtausa.org/our-research/for-researchers/what-is-star/.